Linagliptin, FreeStyle Navigator CGMS System, and EpiPen

Sep 1, 2011
1,564 views

Linagliptin has received approval in Europe for the treatment of type 2 diabetes.

Abbott is permanently discontinuing the FreeStyle Navigator CGMS System in the U.S. Supplies will continue to be available until March 2012.

EpiPen and EpiPen Jr single packages have been discontinued and will be supplied in 2-Paks only.